Serena Jingchuan Guo, M.D., Ph.D., an assistant professor of pharmaceutical outcomes and policy and the studys senior author, said these findings may point to new therapeutic uses for drugs commonly used to treat Type 2 diabetes and obesity
The final sample ( N = 20) consisted of majority white females, with a mean age of ~ 36 years and mean BMI of ~ 38
In addition to cosmetic benefits, it may also contribute to improved healing, better tissue integrity, and enhanced overall function across multiple organ systems
Det bidrar til nytralisere og fjerne skadelige stoffer fra kroppen, samt sttte et balansert immunforsvar
doi:10.1097/00005053-200111000-00004
Endocrine (2016) 51(2):32332.10.1007/s12020-015-0667-x 29 LuNSunHYuJWangXLiuDZhaoLet alGlucagon-like peptide-1 receptor agonist liraglutide has anabolic bone effects in ovariectomized rats without diabetes